Here, we demonstrate clear evidence of the lysosomal sequestration of GnRHR-targeted crizotinib–GnRH conjugates, a phenomenon which should be taken into account in the development of anti-cancer GnRH conjugates with therapeutic value. This evidence concerns the gene GNRH1 and cancer.